We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

25 hedge funds and large institutions have $58M invested in ProQR Therapeutics in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more capital invested

Capital invested by funds: $44.3M → $58M (+$13.7M)

4% less funds holding

Funds holding: 26 → 25 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

45% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 11

Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
11
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HCMT
Highland Capital Management (Texas)
Texas
+$569K
2
M&T Bank
M&T Bank
New York
+$68.3K
3
JP Morgan Chase
JP Morgan Chase
New York
+$33.1K
4
AGA
Altrinsic Global Advisors
Connecticut
+$30.6K
5
Morgan Stanley
Morgan Stanley
New York
+$19.3K

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$2.06M
2
Jennison Associates
Jennison Associates
New York
-$305K
3
SM
Sabby Management
Florida
-$281K
4
Millennium Management
Millennium Management
New York
-$212K
5
Deutsche Bank
Deutsche Bank
Germany
-$74.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
1
Jennison Associates
New York
$17.5M -$305K -55,410 -2%
O
2
OrbiMed
New York
$15.4M – – –
BBA
3
Baker Bros. Advisors
New York
$5.74M -$2.06M -373,631 -30%
RG
4
Redmile Group
California
$3.84M -$31.8K -5,775 -1%
ClearBridge Investments
5
ClearBridge Investments
New York
$3.33M -$29.4K -5,345 -1%
JHIU
6
Janus Henderson Investors US
Colorado
$2.68M -$54.4K -9,887 -2%
Franklin Resources
7
Franklin Resources
California
$2.07M – – –
HCMT
8
Highland Capital Management (Texas)
Texas
$1.71M +$569K +103,379 +67%
Fidelity Investments
9
Fidelity Investments
Massachusetts
$1.59M – – –
AGA
10
Altrinsic Global Advisors
Connecticut
$1.4M +$30.6K +5,556 +3%
Millennium Management
11
Millennium Management
New York
$996K -$212K -38,598 -21%
Principal Financial Group
12
Principal Financial Group
Iowa
$510K – – –
SM
13
Sabby Management
Florida
$393K -$281K -51,090 -46%
Asset Management One
14
Asset Management One
Japan
$255K -$23.7K -4,304 -10%
Morgan Stanley
15
Morgan Stanley
New York
$226K +$19.3K +3,500 +12%
M&T Bank
16
M&T Bank
New York
$83K +$68.3K +12,416 New
JP Morgan Chase
17
JP Morgan Chase
New York
$80K +$33.1K +6,019 +100%
CLM
18
ClearBridge LLC (Maryland)
Maryland
$74K -$38.5K -7,000 -39%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$73K +$325 +59 +0.5%
Wells Fargo
20
Wells Fargo
California
$73K +$16.2K +2,935 +36%
Deutsche Bank
21
Deutsche Bank
Germany
$9K -$74.1K -13,460 -90%
CCM
22
Cribstone Capital Management
Maine
$6K +$5.5K +1,000 New
TRCT
23
Tower Research Capital (TRC)
New York
$5K – – –
Creative Planning
24
Creative Planning
Kansas
$3K -$6.05K -1,100 -73%
Royal Bank of Canada
25
Royal Bank of Canada
Ontario, Canada
$3K – – –
1
2

PRQR Hedge Fund Activity: Q3 2016 in Review

25 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q3 2016, worth a combined $58M — up 31% from $44.3M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PRQR and 2 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 6 added.

The largest buyer was Highland Capital Management (Texas), adding an estimated $569K. The largest seller was Baker Bros. Advisors, cutting an estimated $2.06M.

  • 25 institutional investors held ProQR Therapeutics (PRQR) as of Q3 2016, down from 26 in Q2 2016.
  • Funds reported $58M of ProQR Therapeutics stock for Q3 2016, up 31% quarter-over-quarter.
  • 2 funds opened new ProQR Therapeutics positions in Q3 2016 and 3 closed out, a net change of -1 holder.
  • The largest ProQR Therapeutics buyer in Q3 2016 was Highland Capital Management (Texas), an estimated $569K added.
  • The largest ProQR Therapeutics seller in Q3 2016 was Baker Bros. Advisors, an estimated $2.06M sold.

Based on aggregated 13F filings for Q3 2016.